Firms
Curie.Bio
A biotechnology venture firm and drug-discovery support platform that funds therapeutics startups and provides shared scientific, operational and development expertise. It supports founders from early research through clinical proof of concept, using seed and follow-on investment vehicles.
- Founded
- —
- Type
- Venture capital
Funds2
Curie Bio Seed Fund II, L.P.$342M
Second seed investment fund for therapeutics startups. SEC Form D reports the entire USD 342,075,000 offering sold; the firm publicly announced approximately USD 340 million. This record uses the exact disclosed legal-vehicle amount.
Pro Rata Series A Fund$380M
USD 380 million follow-on fund announced by Curie.Bio to support portfolio companies through Series A financing and clinical development. Name follows the firm’s public announcement; an undisclosed legal vehicle name is not inferred. Date records the firm’s June 27 public announcement.
Team
Alexis Borisy Curie.Bio, Operating Chairman | —— – — | |
Ben Auspitz Curie.Bio, Managing Partner, Breakout Fund | —— – — | |
| —— – — | ||
| —— – — |
Operations and support
Alex BeardDirector, Software Engineering |
Alexia KedvesSenior Director, CSO Partner Team |
Andrea McCoolAssociate Director, Talent Partner |
Andrew WarrenSenior Director, CSO Partner Team |
Andrey BuzukSenior Manager, New Opportunities |
Andy GarnerSVP, CSO Partner Team |
Angela SchmittResearch Strategy and Operations Lead |
Antoine HenninotSenior Director, Drug Maker, Peptide Chemistry |
Aron JaffeSVP, Head of Bleeding Edge |
Arun ThottumkaraSenior Director, Drug Maker, Chemistry |
Avery WackerTalent Sourcing Manager |
Barbara TejadaTalent Manager |
Betty LiuInvestment Analyst, Breakout Fund |
Carlos Garcia-EcheverriaSenior Advisor - Drug Discovery & Development |
Carrie Hyo-Eun BhangSenior Director, Drug Maker, Biology |
Chandra MiduturuSenior Director, Drug Maker, Chemistry |
Charles SaginarioVP, External R&D Operations |
Chris De SaviCSO Partner |
Chris SmithVP, CSO Partner Team |
Chris YatesVP, Drug Maker, Chemistry |
Christina MajerSenior Director, External R&D Operations |
Christophe MullerChief of External R&D and Partnering |
Christopher HoelSenior Associate, CSO Partner Team |
Christopher SneeringerSenior Director, External R&D Operations |
Clinton BourbonaisSenior Director, Founder Strategy and Operations |
Cristina PuchadesAssociate, CSO Partner Team |
Crystal Shih ByersSenior Director, Drug Maker, Biology |
Cynthia BrisacSenior Director, New Products Strategy |
Dan TraskVP, Talent Lead |
Dana DueySenior Director, External R&D Operations |
David GrayCXO |
David HacknerVP, Business Operations |
David TullySVP, Drug Maker, Chemistry |
Deborah MeshulamSVP, Drug Maker, Biologics |
Dennis ZallerPartner (Immunology) |
Devin QuinlanInvestment Principal, Breakout Fund |
Emily HickeyVP, External R&D CRO Relationships |
Emily MatsonDirector, HR Business Partner |
Eric ParkerSenior Advisor - Neuroscience |
Erica EvansSVP, Drug Maker, Biology |
Erik MeredithSVP, Drug Maker, Chemistry |
Flor LeandreSenior Executive Assistant |
Francois RousseauSenior Director, Drug Maker, Biologics |
Frank StegmeierCSO Partner |
George VorenVP, Founder Strategy and Operations |
Greg CarvenPartner (Biologics) |
Guido BoehmeltSVP, Ambassador to Europe |
Hannah BrennerSenior Manager, HR Operations |
Helen SunPrincipal, CSO Partner Team |
Jack LiufuManager, Expert Network |
Jane KennySVP, Drug Maker, DMPK |
Jason KatzVP, Drug Maker, Chemistry |
Jenn MemmottSenior Director, ERAD CRO Relationships |
Jeroen VerheijenVP, Project & Portfolio Management |
Jessica ChambersDirector, Executive Talent Partner |
John BlankenshipVP, Drug Maker, Biologics |
John HerrmannSVP, New Products Strategy |
John XiongVP, Drug Maker, Preclinical Development |
Jon TerrettCXO |
Jordane DimidschsteinSenior Director, Drug Maker, Operations |
Joshua MugfordSenior Director, Drug Maker, Biology |
Julia GuoAssociate Director, Talent Partner |
Jun KuaiVP, Drug Maker, Discovery Biology |
Kelly MoynihanInvestment Principal, Breakout Fund |
Kevin HartDirector, Strategic Finance and Operations |
Lazar BojicVP, Investor Network |
Leah SibenerSenior Director, CSO Partner Team |
Lily ChukovaVP, Executive Talent Partner |
Lisa HuangSVP, CSO Partner Team |
Liv KeefeTalent Sourcing Manager |
Luciano ApponiVP, Drug Maker, Oligonucleotides |
Maddie RufSenior Executive Assistant |
Madison GoldsteinManager, New Opportunities |
Mariela JaskelioffVP, CSO Partner Team |
Mary O'SullivanPrincipal, CSO Partner Team |
Masoud SadaghianiSenior Director, Drug Maker, Biology |
Max RobinsonDirector, Talent Partner |
Megan LambSenior Executive Assistant |
Mert AktarCXO |
Michael RobinsonVP, Drug Maker, Project Management and Operations |
Michelle SoutheyVP, Drug Maker, Computational Chemistry |
Mike SchlabachSVP, CSO Partner Team |
Mike SintchakVP, Drug Maker, Structural Biology and Protein Sciences |
Minsoo KhangInvestment Associate, Breakout Fund |
Molly ColeSenior Associate, CSO Partner Team |
Morgan BreitmeyerVP, Head of Data Product & Engineering |
Mylene PerreaultVP, Drug Maker, Preclinical Development |
Nadine HillAssociate Director, Executive Sourcing |
Natasha MühlemannSVP, Clinical Development |
Neal PadteSVP, Operator |
Nina KreymborgSVP, CSO Partner Team |
Oleg SchmidtVP, Drug Maker, Biomarkers |
Patrick LeeVP, CSO Partner Team |
Patrick LupardusVP, Drug Maker, Biologics |
Philippe DeleriveSVP, CSO Partner Team |
Ping LiSVP, Drug Maker, Biologics |
PV SivakumarVP, CSO Partner Team |
Rainer WilckenSenior Director, Drug Maker, Computational Chemistry |
Raynie SmithVP, People |
Sarah BanquierVP, Executive Talent Partner |
Sarah LengauerSenior Executive Assistant |
Saryah AzmatCXO |
Semi TrottoChief People Officer |
Sofia PhelpsTalent Sourcing Manager |
Stefan GrossSVP Drug Maker, Biology |
Steven EdgarDirector, Special Projects |
Sue WeeSVP, CSO Partner Team |
Tiffany YangTalent Specialist |
Tom HotchkissChief Infrastructure Officer |
Tony WiemeltHead of Investment Diligence and Operations |
Vered GigiVP, Ambassador, Ex-US |
Vivek (Vic) KadambiSVP, Drug Maker, Product Development (CMC and Nonclinical) |
Wenyan MiaoSVP, CSO Partner Team |
Wes TrotterSVP, Drug Maker, Chemistry |
William LeongSVP, Drug Maker, CMC |
Xin HuangSVP, Drug Maker, Protein Sciences and Structural Biology |
Yue PanSenior Director, Drug Maker, Chemistry |
Zara MajidTalent & HR Specialist |
Co-investing
No co-investors on record yet.
Investments
No investment rounds on record yet.